GADA testing: The current state of knowledge

Primary Care Diabetes

Volumn 3, Issue 3, 2009, Pages 189-191

  Davies, H ^a   Brophy, S ^a   Bain, S C ^b   Stephens, J W ^b   Lewis, J ^c   Luzio, S ^d   Dunseath, G ^d   Beaverstock, C ^e   Williams, D R R ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b SWANSEA UNIVERSITY   (United Kingdom)

^c SINGLETON HOSPITAL   (United Kingdom)

^d LLANDOUGH HOSPITAL   (United Kingdom)

^e Neath Port Talbot Hospital   (United Kingdom)

Author keywords

Glutamic acid decarboxylase autoantibodies; Latent autoimmune diabetes in adults

Indexed keywords

GLUTAMATE DECARBOXYLASE ANTIBODY; INSULIN; SULFONYLUREA;

ANTIBODY TITER; ARTICLE; DIABETES MELLITUS; DIABETIC PATIENT; EARLY INTERVENTION; EUROPE; HUMAN; IMMUNOASSAY; INSULIN TREATMENT; PRIORITY JOURNAL; STANDARDIZATION; UNITED KINGDOM; WORLD HEALTH ORGANIZATION;

EID: 70349969799     PISSN: 17519918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcd.2009.07.002     Document Type: Note

References (17)

1. Brophy S., Yderstraede K., Mauricio D., Hunter S., Hawa M., Pozzilli P., Schernthaner G., Schloot N., Buzzetti R., Davies H., Leslie D., and Williams R. Time to insulin initiation cannot be used in defining latent autoimmune diabetes in adults. Diabetes Care 31 3 (2008) 439-441
2. Gale E.A. Latent autoimmune diabetes in adults: a guide for the perplexed. Diabetologia 48 11 (2005) 2195-2199
3. Buzzetti R., Di Pietro S., Giaccari A., Petrone A., Locatelli M., Suraci C., Capizzi M., Arpi M.L., Bazzigaluppi E., Dotta F., and Bosi E. High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes. Diabetes Care 30 4 (2007) 932-938
4. Lindholm E., Hallengren B., and Agardh C.D. Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases. Diabetes Metab. Res. Rev. 20 2 (2004) 158-164
5. Turner R., Stratton I., Horton V., Manley S., Zimmet P., Mackay I.R., Shattock M., Bottazzo G.F., and Holman R. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet 350 9087 (1997) 1288-1293
6. Kasuga A., Maruyama T., Nakamoto S., Ozawa Y., Suzuki Y., and Saruta T. High-titer autoantibodies against glutamic acid decarboxylase plus autoantibodies against insulin and IA-2 predicts insulin requirement in adult diabetic patients. J. Autoimmun. 12 2 (1999) 131-135
7. Torn C., Mueller P.W., Schlosser M., Bonifacio E., and Bingley P.J. Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2. Diabetologia 51 5 (2008) 846-852
8. Glutamic Acid Decarboxylase (GAD) Autoantibody ELISA Kit from RSR-Instructions for Use, 2007, www.rsrltd.com (cited).
9. van Deutekom A.W., Heine R.J., and Simsek S. The islet autoantibody titres: their clinical relevance in latent autoimmune diabetes in adults (LADA) and the classification of diabetes mellitus. Diabet. Med. 25 2 (2008) 117-125
10. Brophy S., Brunt H., Davies H., Mannan S., and Williams R. Interventions for latent autoimmune diabetes (LADA) in adults. Cochrane Database Syst. Rev. 3 (2007) CD006165
11. Hamaguchi K., Kimura A., Kusuda Y., Yamashita T., Yasunami M., Takahasi M., Abe N., and Yoshimatsu H. Clinical and genetic characteristics of GAD-antibody positive patients initially diagnosed as having type 2 diabetes. Diabetes Res. Clin. Pract. 66 2 (2004) 163-171
12. Takeda H., Kawasaki E., Shimizu I., Konoue E., Fujiyama M., Murao S., Tanaka K., Mori K., Tarumi Y., Seto I., Fujii Y., Kato K., Kondo S., Takada Y., Kitsuki N., Kaino Y., Kida K., Hashimoto N., Yamane Y., Yamawaki T., Onuma H., Nishimiya T., Osawa H., Saito Y., Makino H., and Clinical. autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime Study). Diabetes Care 25 6 (2002) 995-1001
13. Davies H., Mannan S., Brophy S., and Williams R. Routine glutamic acid decarboxylase autoantibody (GADA) testing: patients' perspective. Fam. Pract. 25 3 (2008) 176-180
14. Davies H., Brophy S., Bain S.C., Stephens J.W., Lewis J., Beaverstock C., and Williams D.R.R. Routine glutamic acid decarboxylase antibody testing: health professionals' perspective in Abstracts of Diabetes UK Professional Conference. Diabet. Med. 26 Suppl. 1 (2009) 193
15. Glutamic Acid Decarboxylase (GAD) Autoantibody ELISA Kit from RSR-Instructions for Use, 2007, www.rsrltd.com (cited March 2009).
16. Davies H., Brophy S., Fielding A., Bingley P., Chandler M., Hilldrup I., Brooks C., and Williams R. Latent autoimmune diabetes in adults (LADA) in South Wales: incidence and characterization. Diabet. Med. 25 11 (2008) 1354-1357
17. Diabetes Atlas, third edition, International Diabetes Federation, 2008, www.eatlas.idf.org.